US$ 24.74
glp-1 and kidney function receptor agonists effects on established presumed drivers of Renal effects of GLP-1 receptor
Description
Serving Size:1 Capsule

Eli Lilly and Novo Nordisk are closing in on deals with the Trump administration that would exchange deep discounts on their weight loss drugs for coverage under Medicare, per Endpoints News

The renewal conversation is harder to have

However, the structural complexity and conformational plasticity of class B1 GPCRs make conventional single-method virtual screening approaches prone to bias and limited chemotype recovery

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics
